E. coli News and Research

RSS
E. coli or Escherichia coli is the name of a type of bacteria that lives in your intestines. Most types of E. coli are harmless. However, some types can make you sick and cause diarrhea. One type causes travelers' diarrhea. The worst type of E. coli causes bloody diarrhea, and can sometimes cause kidney failure and even death. These problems are most likely to occur in children and in adults with weak immune systems. You can get E. coli infections by eating foods containing the bacteria. To help avoid food poisoning and prevent infection, handle food safely. Cook meat well, wash fruits and vegetables before eating or cooking them, and avoid unpasteurized milk and juices. You can also get the infection by swallowing water in a swimming pool contaminated with human waste. Most cases of E. coli infection get better without treatment in 5 to 10 days.

Further Reading

Study finds ST131 a major cause of antimicrobial-resistant E. coli infections

Study finds ST131 a major cause of antimicrobial-resistant E. coli infections

Down the silk road of the future

Down the silk road of the future

GSK exercises option to obtain exclusive licence to develop, commercialise GSK '052

GSK exercises option to obtain exclusive licence to develop, commercialise GSK '052

Mobile phones dirtier than we thought: Study

Mobile phones dirtier than we thought: Study

Vitro Diagnostics, Mokshagundam Biotechnologies enter contract to develop stem cell-derived food

Vitro Diagnostics, Mokshagundam Biotechnologies enter contract to develop stem cell-derived food

BiondVax receives 2010 European Influenza Vaccines Technology Innovation Award

BiondVax receives 2010 European Influenza Vaccines Technology Innovation Award

Mediomics receives additional $460,000 in STTR Phase II grant for PINCER protein assay development

Mediomics receives additional $460,000 in STTR Phase II grant for PINCER protein assay development

Advanced Life Sciences enters agreement with UBC to develop antimicrobial peptides

Advanced Life Sciences enters agreement with UBC to develop antimicrobial peptides

Tarsa Therapeutics completes patient enrollment in Phase III ORACAL trial of oral calcitonin

Tarsa Therapeutics completes patient enrollment in Phase III ORACAL trial of oral calcitonin

Novartis, Nordic Bioscience to continue oral calcitonin Phase III study in osteoarthritis patients

Novartis, Nordic Bioscience to continue oral calcitonin Phase III study in osteoarthritis patients

Meridian Bioscience third-quarter net sales decrease 11% to $33.9 million

Meridian Bioscience third-quarter net sales decrease 11% to $33.9 million

DBS signs exclusive license agreement with JLB

DBS signs exclusive license agreement with JLB

WPI researchers measure molecular forces that enable cranberry juice to fight off urinary tract infections

WPI researchers measure molecular forces that enable cranberry juice to fight off urinary tract infections

Cubist Pharmaceuticals total net revenues for second-quarter 2010 increase 29%

Cubist Pharmaceuticals total net revenues for second-quarter 2010 increase 29%

ALLOZYNE signs worldwide licensing agreement with The Scripps Research Institute

ALLOZYNE signs worldwide licensing agreement with The Scripps Research Institute

New Cystex Liquid Cranberry Complex with Proantinox reduces incidence of UTIs in women: Study

New Cystex Liquid Cranberry Complex with Proantinox reduces incidence of UTIs in women: Study

Protein acetylation not rare in bacteria

Protein acetylation not rare in bacteria

Federal food safety agencies commended for supporting Food Safety Working Group

Federal food safety agencies commended for supporting Food Safety Working Group

Vitamin D receptor emerges as key player amid gut bacteria, scientists find

Vitamin D receptor emerges as key player amid gut bacteria, scientists find

Medizone seeks international patent protection for Asepticsure technology

Medizone seeks international patent protection for Asepticsure technology

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.